Philip V Theodosopoulos
Overview
Explore the profile of Philip V Theodosopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shukla P, Nguyen M, Lui A, Catalan T, Young J, Berger M, et al.
J Neurosurg
. 2025 Feb;
:1-9.
PMID: 39951711
Objective: Tumor mutational burden (TMB) has been proposed as a prognostic biomarker in patients with metastatic cancer, as well as in patients who receive immune checkpoint inhibitor (ICI) therapy. However,...
2.
Morshed R, Nguyen M, Choudhury A, Al-Adli N, Magill S, Haddad A, et al.
Neurosurgery
. 2025 Jan;
PMID: 39773932
Background And Objectives: Extent of resection (EOR) is prognostic for meningioma outcomes. DNA methylation profiling can shed light on biological drivers and therapeutic vulnerabilities. The goal of this study was...
3.
Ramesh R, Quintana D, Osorio R, Jimenez C, Aghi M, McDermott M, et al.
Neurosurgery
. 2024 Dec;
PMID: 39699183
Background And Objectives: Intracranial epidermoid cysts are rare, slow-growing but highly recurrent tumors with incompletely understood symptoms, progression, complications, and outcomes. The aim of the study was to characterize the...
4.
Lucas C, Al-Adli N, Young J, Gupta R, Morshed R, Wu J, et al.
Neuro Oncol
. 2024 Nov;
27(1):89-105.
PMID: 39560080
Background: Despite recent advances in the biology of IDH-wildtype glioblastoma, it remains a devastating disease with median survival of less than 2 years. However, the molecular underpinnings of the heterogeneous...
5.
Morshed R, Nguyen M, Youngblood M, Perlow H, Lucas C, Patel A, et al.
Neurosurgery
. 2024 Aug;
96(3):521-528.
PMID: 39101743
Background And Objective: Patients who undergo gross total resection (GTR) of Central Nervous System World Health Organization (WHO) grade 1 meningioma constitute a "low-risk" group, but some low-risk meningiomas can...
6.
Mirian C, Rehne Jensen L, Juratli T, Maier A, Torp S, Shih H, et al.
J Neurooncol
. 2024 Feb;
166(3):503-511.
PMID: 38336917
Background: The risk of recurrence is overestimated by the Kaplan-Meier method when competing events, such as death without recurrence, are present. Such overestimation can be avoided by using the Aalen-Johansen...
7.
Liu S, Casey-Clyde T, Cho N, Swinderman J, Pekmezci M, Dougherty M, et al.
Nat Commun
. 2024 Jan;
15(1):476.
PMID: 38216587
Mechanisms specifying cancer cell states and response to therapy are incompletely understood. Here we show epigenetic reprogramming shapes the cellular landscape of schwannomas, the most common tumors of the peripheral...
8.
Umbach G, Tran E, Eaton C, Choudhury A, Morshed R, Villanueva-Meyer J, et al.
Oper Neurosurg (Hagerstown)
. 2024 Jan;
PMID: 38189372
Background And Objectives: Meningiomas are the most common primary intracranial tumors and are among the only tumors that can form lamellar, hyperostotic bone in the tumor microenvironment. Little is known...
9.
Andrews J, Cummins D, Morshed R, Kinde B, Aghi M, McDermott M, et al.
J Neurosurg
. 2023 Oct;
140(4):1001-1007.
PMID: 37877997
Objective: Intraventricular meningiomas (IVMs) of the lateral ventricle are rare tumors that present surgical challenges because of their deep location. Visual field deficits (VFDs) are one risk associated with these...
10.
Osorio R, Haddad A, Hart D, Goldrich N, Badani A, Kabir A, et al.
J Neurosurg
. 2023 Oct;
140(3):712-723.
PMID: 37877974
Objective: Socioeconomic status (SES) is known to affect presentations and outcomes in pituitary neuroendocrine tumor resections, but there is a paucity of literature examining its impact specifically on patients with...